283 related articles for article (PubMed ID: 12615729)
61. Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking.
Hughes EG; Maguire JL; McMinn MT; Scholz RE; Sutherland ML
Brain Res Mol Brain Res; 2004 May; 124(2):114-23. PubMed ID: 15135219
[TBL] [Abstract][Full Text] [Related]
62. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
[TBL] [Abstract][Full Text] [Related]
63. Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction.
Hagemann TL; Gaeta SA; Smith MA; Johnson DA; Johnson JA; Messing A
Hum Mol Genet; 2005 Aug; 14(16):2443-58. PubMed ID: 16014634
[TBL] [Abstract][Full Text] [Related]
64. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
[TBL] [Abstract][Full Text] [Related]
65. Down-regulation of integrin alpha2 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation.
Ning Y; Zeineldin R; Liu Y; Rosenberg M; Stack MS; Hudson LG
Cancer Res; 2005 Oct; 65(20):9280-6. PubMed ID: 16230389
[TBL] [Abstract][Full Text] [Related]
66. GFAP promoter elements required for region-specific and astrocyte-specific expression.
Lee Y; Messing A; Su M; Brenner M
Glia; 2008 Apr; 56(5):481-93. PubMed ID: 18240313
[TBL] [Abstract][Full Text] [Related]
67. Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts.
Humphrey PA; Wong AJ; Vogelstein B; Friedman HS; Werner MH; Bigner DD; Bigner SH
Cancer Res; 1988 Apr; 48(8):2231-8. PubMed ID: 3258189
[TBL] [Abstract][Full Text] [Related]
68. [Analysis of S100beta-v-erbB transgenic rats prone to brain tumors].
Yokoo H; Tanaka Y; Nobusawa S; Nakazato Y; Ohgaki H
Brain Nerve; 2009 Jul; 61(7):765-72. PubMed ID: 19618853
[TBL] [Abstract][Full Text] [Related]
69. Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma.
Sonoda Y; Ozawa T; Aldape KD; Deen DF; Berger MS; Pieper RO
Cancer Res; 2001 Sep; 61(18):6674-8. PubMed ID: 11559533
[TBL] [Abstract][Full Text] [Related]
70. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.
Holland EC; Hively WP; DePinho RA; Varmus HE
Genes Dev; 1998 Dec; 12(23):3675-85. PubMed ID: 9851974
[TBL] [Abstract][Full Text] [Related]
71. An immunocytochemical comparison of glial fibrillary acidic protein, S-100p and vimentin in human glial tumors.
Nakopoulou L; Kerezoudi E; Thomaides T; Litsios B
J Neurooncol; 1990 Feb; 8(1):33-40. PubMed ID: 2319288
[TBL] [Abstract][Full Text] [Related]
72. Use of GFAP-lacZ transgenic mice to determine astrocyte fate in grafts of embryonic ventral midbrain.
Quintana JG; Lopez-Colberg I; Cunningham LA
Brain Res Dev Brain Res; 1998 Jan; 105(1):147-51. PubMed ID: 9497089
[TBL] [Abstract][Full Text] [Related]
73. Oncogenic synergism between ErbB1, nucleolin, and mutant Ras.
Farin K; Schokoroy S; Haklai R; Cohen-Or I; Elad-Sfadia G; Reyes-Reyes ME; Bates PJ; Cox AD; Kloog Y; Pinkas-Kramarski R
Cancer Res; 2011 Mar; 71(6):2140-51. PubMed ID: 21257709
[TBL] [Abstract][Full Text] [Related]
74. The epidermal growth factor receptor: from development to tumorigenesis.
Sibilia M; Kroismayr R; Lichtenberger BM; Natarajan A; Hecking M; Holcmann M
Differentiation; 2007 Nov; 75(9):770-87. PubMed ID: 17999740
[TBL] [Abstract][Full Text] [Related]
75. Uniform lineage of oligodendrogliomas.
de la Monte SM
Am J Pathol; 1989 Sep; 135(3):529-40. PubMed ID: 2675625
[TBL] [Abstract][Full Text] [Related]
76. A mouse model for glioma: biology, pathology, and therapeutic opportunities.
Holland EC
Toxicol Pathol; 2000; 28(1):171-7. PubMed ID: 10669005
[TBL] [Abstract][Full Text] [Related]
77. In contrast to EGFr gene overexpression, H-ras gene expression decreases in human gliomas.
Blumenstock M; Prosenc N; Patt S; Pfanne K; Drum F; Cervos-Navarro J
Anticancer Res; 1991; 11(3):1353-7. PubMed ID: 1888172
[TBL] [Abstract][Full Text] [Related]
78. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
Chen Y; Zhang YX
Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
[TBL] [Abstract][Full Text] [Related]
79. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens.
Feldkamp MM; Lala P; Lau N; Roncari L; Guha A
Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712
[TBL] [Abstract][Full Text] [Related]
80. [Cell proliferation and glial fibrillary acidic protein in brain tumors].
Kunz J; Gottschalk J; Jänisch W; Schulz W
Acta Histochem; 1986; 80(1):53-61. PubMed ID: 3099535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
